Abraham R J, Stevens A J, Young K A, Russell C, Qvist A, Khazandi M, Wong H S, Abraham S, Ogunniyi A D, Page S W, O Handley R, Mccluskey A, Trott D J. 2016. Robenidine analogues as Gram-positive antibacterial agents. Journal of Medicinal Chemistry, 59, 2126–2138.

Agudelo Higuita N I, Huycke M M. 2014. Enterococcal disease, epidemiology, and implications for treatment. In: Gilmore M S, Clewell D B, Ike Y, Shankar N, eds. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. Massachusetts Eye and Ear Infirmary, Boston.

CARSS (China Antimicrobial Resistance Surveillance System). 2023. Online statistical database: China antimicrobial resistance surveillance for 2022 (Summary version). [2023-11-20]. https://www.carss.cn/Report/Details?aId=917/

Chen M, Lo C. 2016. Using biophysics to monitor the essential protonmotive force in bacteria. In: Leake M C, ed., Biophysics of Infection. Springer International Publishing, Cham. pp. 69–79.

Ciarlantini M S, Barquero A, Bayo J, Wetzler D, Dodes T M, Bucci H A, Fiore E J, Gandolfi D L, Defelipe L, Turjanski A, Ramirez J A, Mazzolini G, Comin M J. 2021. Development of an improved guanidine-based rac1 inhibitor with in vivo activity against non-small cell lung cancer. ChemMedChem, 16, 1011–1021.

Clinical and Laboratory Standards Institute (CLSI). 2020. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100. Wayne (PA): Clinical and Laboratory Standards Institute, USA.

Conwell M, Dooley J, Naughton P. 2022. Enterococcal biofilm-A nidus for antibiotic resistance transfer?. Journal of Applied Microbiology, 132, 3444–3460.

ECFDP (European Centre for Disease Prevention and Control). 2023. Online statistical database: Antimicrobial resistance in the EU/EEA (EARS-Net)-Annual epidemiological report for 2022. [2023-11-17]. https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2022/

Epand R M, Epand R F. 2009. Domains in bacterial membranes and the action of antimicrobial agents. Molecular BioSystems, 5, 580–587.

Flemming H, Wingender J. 2010. The biofilm matrix. Nature Reviews Microbiology, 8, 623–633.

Foss M H, Eun Y, Weibel D B. 2011. Chemical–biological studies of subcellular organization in bacteria. Biochemistry, 50, 7719–7734.

Gomes A R, Varela C L, Pires A S, Tavares-Da-Silva E J, Roleira F M F. 2023. Synthetic and natural guanidine derivatives as antitumor and antimicrobial agents: A review. Bioorganic Chemistry, 138, 106600.

Han N, Li J, Zhao F, Li Y, Wang J, Dai X, Zeng D, Xiong W, Zeng Z. 2023. Isopropoxy benzene guanidine ameliorates Streptococcus suis infection in vivo and in vitro. International Journal of Molecular Sciences, 24, 7354.

Hofkens N, Gestels Z, Abdellati S, Gabant P, Rodriguez-Villalobos H, Martin A, Kenyon C, Manoharan-Basil S S. 2024. Protective effect of microbisporicin (NAI-107) against vancomycin resistant Enterococcus faecium infection in a Galleria mellonella model. Scientific Reports, 14, 4786.

Huang H, Wang P, Deng W, Dou L, Liao X, Wang J, Duan X, Yu R, Xiong Y. 2023. Coumarin-modified ruthenium complexes by disrupting bacterial membrane to combat Gram-positive bacterial infection. Dalton Transactions, 52, 9757–9771.

Jesudason T. 2024. WHO publishes updated list of bacterial priority pathogens. Lancet Microbe, 5, 100940.

de Jong A, Youala M, El Garch F, Simjee S, Rose M, Morrissey I, Moyaert H. 2020. Antimicrobial susceptibility monitoring of canine and feline skin and ear pathogens isolated from European veterinary clinics: Results of the ComPath surveillance programme. Veterinary Dermatology, 31, 114–431.

Joyce L R, Doran K S. 2023. Gram-positive bacterial membrane lipids at the host–pathogen interface. PLoS Pathogens, 19, e1011026.

Kantor S, Kennett R L, Waletzky E, Tomcufcik A S. 1970. 1,3-Bis(p-chlorobenzylideneamino) guanidine hydrochloride (Robenzidene): New poultry anticoccidial agent. Science, 168, 373–374.

Kong L, Lu Y, Yang L, Zhang W, Zuo B, Peng X, Qin Z, Li M, Zeng Z, Zeng D. 2022. Pharmacokinetics and pharmacodynamics of colistin combined with isopropoxy benzene guanidine against mcr-1-positive Salmonella in an intestinal infection Model. Frontiers in Microbiology, 13, 907116.

Kuhn S, Slavetinsky C J, Peschel A. 2015. Synthesis and function of phospholipids in Staphylococcus aureus. International Journal of Medical Microbiology, 305, 196–202.

Kwon J, Ko H J, Yang M H, Park C, Park S C. 2022. Antibiotic resistance and species profile of Enterococcus species in dogs with chronic otitis externa. Veterinary Sciences, 9, 592.

Laxminarayan R, Duse A, Wattal C, Zaidi A K, Wertheim H F, Sumpradit N, Vlieghe E, Hara G L, Gould I M, Goossens H, Greko C, So A D, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta A Q, Qamar F N, Mir F, Kariuki S, et al. 2013. Antibiotic resistance-the need for global solutions. Lancet Infectious Diseases, 13, 1057–1098.

Lebreton F, Le Bras F, Reffuveille F, Ladjouzi R, Giard J, Leclercq R, Cattoir V. 2012. Galleria mellonella as a model for studying Enterococcus faecium host persistence. Journal of Molecular Microbiology and Biotechnology, 21, 191–196.

Li J, Zhang X, Han N, Wan P, Zhao F, Xu T, Peng X, Xiong W, Zeng Z. 2023. Mechanism of action of isopropoxy benzene guanidine against multidrug-resistant pathogens. Microbiology Spectrum, 11, e0346922.

Liang P, Shen S, Xu Q, Wang S, Jin S, Lu H, Dong Y, Zhang J. 2021. Design, synthesis biological activity, and docking of novel fluopyram derivatives containing guanidine group. Bioorganic & Medicinal Chemistry, 29, 115846.

Lim S Y, Teh C S J, Thong K L. 2017. Biofilm-related diseases and omics: Global transcriptional profiling of Enterococcus faecium reveals different gene expression patterns in the biofilm and planktonic cells. OMICS: A Journal of Integrative Biology, 21, 592–602.

Lu Y, Qiao W, Xue Y, Hong X, Jin Y, Li J, Peng X, Zeng D, Zeng Z. 2024. Antibacterial activity of isopropoxy benzene guanidine against Riemerella anatipestifer. Frontiers in Pharmacology, 15, 1347250.

Lu Y, Yang L, Zhang W, Li J, Peng X, Qin Z, Zeng Z, Zeng D. 2022. Pharmacokinetics and pharmacodynamics of isopropoxy benzene guanidine against Clostridium perfringens in an intestinal infection model. Frontiers in Veterinary Science, 9, 1004248.

Lu Y, Zhang W, Zhang Y, Wu S, Ma M, Peng X, Zeng Z, Zeng D. 2023. Metabolite identification of isopropoxy benzene guanidine in rat liver microsomes by using UHPLC-Q-TOF-MS/MS. International Journal of Molecular Sciences, 24, 7313.

Nguyen M, Chung E P. 2005. Telithromycin: The first ketolide antimicrobial. Clinical Therapeutics, 27, 1144–1163.

Ogunniyi A D, Khazandi M, Stevens A J, Sims S K, Page S W, Garg S, Venter H, Powell A, White K, Petrovski K R, Laven-Law G, Tótoli E G, Salgado H R, Pi H, Coombs G W, Shinabarger D L, Turnidge J D, Paton J C, Mccluskey A, Trott D J, et al. 2017. Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent. PLoS ONE, 12, e0183457.

Pasero C, D’Agostino I, De Luca F, Zamperini C, Deodato D, Truglio G I, Sannio F, Del P R, Ferraro T, Visaggio D, Mancini A, Guglielmi M B, Visca P, Docquier J D, Botta M. 2018. Alkyl-guanidine compounds as potent broad-spectrum antibacterial agents: Chemical library extension and biological characterization. Journal of Medicinal Chemistry, 61, 9162–9176.

Peng X F. 2019. Application of Diaminoguanidine Derivatives and Their Feed Compositions in the Preparation of Veterinary Drugs. China Patent, Application CN201980005962.7. China National Intellectual Property Administration, Beijing, China. (in Chinese)

Raheem N, Straus S K. 2019. Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions. Frontiers in Microbiology, 10, 2866.

Shen B, Wang M, Xu S, Gao C, Wang M, Li S, Ampomah-Wireko M, Chen S, Yan D, Qin S, Zhang E. 2022. Antibacterial efficacy evaluation and mechanism probe of small lysine chalcone peptide mimics. European Journal of Medicinal Chemistry, 244, 114885.

Thieme L, Hartung A, Makarewicz O, Pletz M W. 2020. In vivo synergism of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis assessed in the Galleria mellonella infection model. Journal of Antimicrobial Chemotherapy, 75, 2173–2181.

Turnidge J, Kahlmeter G, Kronvall G. 2006. Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. Clinical Microbiology and Infection, 12, 418–425.

Wang J, Wang Y, Li Z, Zhan P, Bai R, Pannecouque C, Balzarini J, De Clercq E, Liu X. 2014. Design, synthesis and biological evaluation of substituted guanidine indole derivatives as potential inhibitors of HIV-1 Tat-TAR interaction. Medicinal Chemistry, 10, 738–746.

Wang Y, Xiong Y, Wang Z, Zheng J, Xu G, Deng Q, Wen Z, Yu Z. 2021. Comparison of solithromycin with erythromycin in Enterococcus faecalis and Enterococcus faecium from China: Antibacterial activity, clonality, resistance mechanism, and inhibition of biofilm formation. The Journal of Antibiotics, 74, 143–151.

Xiong Y, Chen J, Sun X, Xu G, Li P, Deng Q, Yu Z, Chen Z, Zheng J. 2021. The antibacterial and antibiofilm activity of telithromycin against Enterococcus spp. isolated from patients in China. Frontiers in Microbiology, 11, 616797.

Xu W, Fang Y, Zhu K. 2024. Enterococci facilitate polymicrobial infections. Trends in Microbiology, 32, 162–177.

Yang B, Tong Z, Shi J, Wang Z, Liu Y. 2023. Bacterial proton motive force as an unprecedented target to control antimicrobial resistance. Medicinal Research Reviews, 43, 1068–1090.

Yang R, Cheng W, Huang M, Xu T, Zhang M, Liu J, Qin S, Guo Y. 2024. Novel membrane-targeting isoxanthohumol-amine conjugates for combating methicillin-resistant Staphylococcus aureus (MRSA) infections. European Journal of Medicinal Chemistry, 268, 116274.

Zhang X, Han D, Pei P, Hao J, Lu Y, Wan P, Peng X, Lv W, Xiong W, Zeng Z. 2019. In vitro antibacterial activity of isopropoxy benzene guanidine against multidrug-resistant Enterococci. Infection and Drug Resistance, 12, 3943–3953.

Zhang X, Xiong W, Peng X, Lu Y, Hao J, Qin Z, Zeng Z. 2021. Isopropoxy benzene guanidine kills Staphylococcus aureus without detectable resistance. Frontiers in Microbiology, 12, 633467.